
Zetaglim M 3mg/500mg Tablet SR
Marketer
Elinor Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (3mg) + Metformin (500mg)
Overview Zetaglim M 3mg/500mg Tablet SR
Diabetic patients using the extended-release combination medication, Zetaglim M 3mg/500mg, benefit from its dual-action approach to blood glucose management. This anti-diabetic formulation, specifically for adult type 2 diabetes, helps regulate blood sugar. Consistent daily intake, always with food and at the same time, maximizes its effectiveness. Dosage is individualized and adjusted by your physician based on your blood sugar response. Discontinuing this medication without medical guidance is strongly discouraged, as it can lead to uncontrolled blood sugar, potentially causing severe complications including kidney impairment, vision loss, neuropathy, and limb damage. Remember, this drug is part of a comprehensive diabetes management plan which includes a balanced diet, regular physical activity, and weight management as directed by your doctor. Commonly, Zetaglim M can cause hypoglycemia (low blood sugar). Learn to recognize its symptoms – sweating, lightheadedness, headache, and tremors – and know how to treat it promptly using a fast-acting glucose source (e.g., sugary foods, fruit juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also a potential consequence. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Patients with a history of heart conditions should discuss its use with their physician. Pregnant or nursing mothers must also seek medical advice before starting this treatment. Regular blood sugar monitoring, along with periodic blood tests to assess blood cell counts and liver function, are essential components of treatment.
Uses of Zetaglim M 3mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Zetaglim M 3mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or divide it. Consume Zetaglim M 3mg/500mg Extended-Release Tablets with food.
Common Side effects of Zetaglim M 3mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Zetaglim M 3mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Zetaglim M 3mg/500mg SR tablets with a meal.
How Zetaglim M 3mg/500mg Tablet SR works:
Zetaglim M 3mg/500mg sustained-release tablets contain glimepiride and metformin, two anti-diabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Zetaglim M 3mg/500mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Zetaglim M 3mg/500mg SR tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Zetaglim M 3mg/500mg tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.
DrivingCAUTION
Driving may be impaired by abnormally low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Zetaglim M 3mg/500mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. This medication is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Zetaglim M 3mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. Initiation at a reduced dosage is typical for individuals with mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Zetaglim M 3mg/500mg Tablet SR :
Should you forget a dose of Zetaglim M 3mg/500mg SR tablets, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Zetaglim M 3mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
